Vaccine rollout - PowerPoint PPT Presentation


Malaria Vaccines 101

Explore the complexities of malaria vaccine development, targeting Plasmodium species/stages, immunity evidence, and broad vaccine approaches focusing on sub-unit vaccines. Discover the quest for an effective and accessible malaria vaccine.

9 views • 32 slides


Addressing Health Inequalities and Vaccine Hesitancy in Shirebrook: Findings and Strategies

Shirebrook, a deprived area in Derbyshire, has been grappling with health inequalities and vaccine hesitancy, particularly among certain groups like ethnic minorities and those living in deprivation. Efforts have been made to engage the community, resulting in varying levels of vaccine uptake among

1 views • 14 slides



Update on Infectious Disease Prevention and H5N1 Vaccine Production

This content provides updates on infectious disease prevention efforts, including historical data, TB data posting schedule, and HIV surveillance updates. It also highlights the plans of the US Department of Health and Human Services to produce 4.8 million doses of the H5N1 avian flu vaccine for pan

0 views • 7 slides


Making Informed Vaccine Decisions for Your 2-Month-Old Infant

Congratulations on your infant reaching 2 months! Learn about the importance of vaccines and how to make informed decisions regarding vaccinating your baby. Access valuable resources from CDC to understand vaccine benefits and risks. Still unsure? Get familiar with vaccine-preventable diseases and h

0 views • 14 slides


Understanding Polio Eradication Efforts and Vaccine Development

Polio, a disabling disease caused by the poliovirus, mainly affects children and can lead to paralysis. Efforts to eradicate polio include the development of vaccines like the Inactivated Polio Vaccine (IPV) and Oral Polio Vaccine (OPV). The poliovirus' choice of host, ease of transmission, and impa

0 views • 15 slides


Moderna Becomes Third Covid Vaccine Approved in the UK - Important Updates

The UK has approved Moderna as the third Covid vaccine, with logistical challenges due to required storage at -75C. AstraZeneca's vaccine is easier to distribute. Moderna offers nearly 95% protection from severe Covid, but all vaccines require a second dose for optimal immunity. Uncertainty remains

0 views • 7 slides


Overview of Master Facility Lists in Nigeria: Rollout of Health Facility Registry

The document provides an overview of the master facility lists (MFLs) in Nigeria, focusing on the rollout of the Health Facility Registry (HFR) for states and local government areas. It discusses the elements of functional MFLs, the process of facility listing, HFR development, governance plans for

1 views • 16 slides


National COVID-19 Vaccine Deployment and Roll-Out Plan in Zimbabwe

The Republic of Zimbabwe is gearing up for the introduction of a COVID-19 vaccine as part of its response to the pandemic, with a focus on deploying 200,000 doses to priority groups. The comprehensive plan includes key strategies, financing alignment, and integration into national governance mechani

5 views • 28 slides


Health Facility Registry Management Rollout in Nigeria

Managing the rollout of a Health Facility Registry/Master Facility List for states and local government areas in Nigeria involves creating, updating, deleting, and tracking facility records. The process includes data entry, approval procedures, and tracking request statuses for visibility to the pub

0 views • 35 slides


Understanding Vaccine Safety, Effectiveness, and Side Effects: A Guide to Better Living

This informative content delves into vaccine safety, effectiveness, and side effects, offering insights into the development stages of vaccines, COVID-19 vaccine comparisons, and an overview of COVID-19 vaccine development. It also explains how vaccines work to protect against viruses and emphasizes

0 views • 33 slides


Maine eWIC Rollout: Introduction to Produce Mapping

Prepare for the eWIC rollout in Maine by understanding the importance of produce mapping, submitting UPCs for approval, and ensuring items are on the approved product list. Learn how eWIC streamlines transactions and offers flexibility to participants.

0 views • 12 slides


Kenya PrEP Ring Rollout Scenarios Analysis

Analysis conducted by the PROMISE Consortium in January 2022 highlights the prioritized counties for introducing the monthly dapivirine ring as an HIV prevention method for women in Kenya. The scenarios consider HIV incidence among women and current oral PrEP uptake across counties to determine the

0 views • 9 slides


COVID-19 Vaccine Update: Pfizer Vaccine Logistics and Emergency Use Authorization

The update discusses the latest information on Pfizer's COVID-19 vaccine, including details on the new technology, storage requirements, logistics handling, and Emergency Use Authorization (EUA). Pfizer's vaccine, with a 95% efficacy rate, requires storage in ultra-low-temperature freezers or therma

0 views • 28 slides


Enhancements in Causal Forecasting: SPM 11.0.1/11.1 Overview

Key enhancements in SPM 11.0.1/11.1 focus on improving forecast accuracy through variable history slices, causal forecasting for multiple streams, multi-threading capabilities, easy access to product rollout and causal value pages, and more. The Next Gen Causal Forecasting introduces additional feat

0 views • 6 slides


Co-created Messages & Trusted Messengers for COVID-19 Vaccine Acceptance in Northern Nigeria

Dr. Chizoba Wonodi is evaluating the use of co-created messages and trusted messengers to improve COVID-19 vaccine acceptance in Northern Nigeria. Vaccine hesitancy due to conspiracy theories and safety concerns remains a challenge. TM-COVAC study aims to design targeted messages using human-centere

0 views • 8 slides


VASE+ Release 11.4: New Features for Vaccine Management

In the latest VASE+ Release 11.4, several new features have been introduced to enhance vaccine management processes. These include a new vaccine selection field, Pfizer vaccine lot addition for 5-11-year-olds, color coding per vaccine type, customizability options, new columns for vaccine name and s

0 views • 8 slides


Vaccine Administration Best Practices and Waste Management

This content provides valuable information on handling vaccines, including determining vaccine viability, identifying wastage, and understanding expiration dates. It includes scenarios covering vaccine storage, reporting spoiled doses, and managing vial wastage. The answers and explanations offered

0 views • 7 slides


Interrogating the Establishment of Vaccine Plants in Africa: Case Studies of Rwanda and Uganda

Nimrod Muhumuza, from Afya na Haki Institute, presents a critical analysis of vaccine plant setup in Rwanda and Uganda. The discussion focuses on the potential leadership roles of small economies, private sector involvement, sustainability of vaccine production, and the importance of participation f

0 views • 13 slides


IPP Rollout and Support Training Overview

The Invoice Processing Platform (IPP) rollout and support training on November 2, 2017, aimed to introduce a secure, web-based service developed by the Department of the Treasury that facilitates cradle-to-grave government invoicing. The platform is integrated with the OFF 12.1.3 environment, mandat

0 views • 33 slides


Effect of Efgartigimod on Humoral Vaccine Responses in Patients with Autoimmune Diseases

The study explores the impact of Efgartigimod, a Neonatal Fc Receptor blocker, on humoral vaccine responses in patients with autoimmune diseases. It discusses how immunosuppressive therapies used in autoimmune disorders may affect susceptibility to infections and impair vaccine immunogenicity, highl

0 views • 18 slides


Telemedicine Rollout in Secure and Detained Settings

In August 2020, Chantal Edge led the rollout of telemedicine services in secure and detained settings, including prisons, in England. The initiative involved deploying digital technology approved by national security teams and facilitating remote healthcare delivery to inmates through Visionable sof

0 views • 10 slides


Understanding the COVID-19 Vaccine: Information from Illinois Department of Corrections

The Illinois Department of Corrections emphasizes the importance of the COVID-19 vaccine, highlighting its effectiveness in preventing severe illness. Individuals are encouraged to make an informed decision about vaccination, ensuring protection for themselves and others. The department assures that

0 views • 52 slides


COVID-19 Vaccination Rollout Plan in Seychelles

The Republic of Seychelles initiated a COVID-19 vaccination rollout plan to achieve herd immunity, targeting 70,000 out of a total population of about 98,000. The plan involved receiving Sinopharm and Covishield vaccines, prioritizing age groups for vaccination. Seychelles established a National Tec

0 views • 18 slides


Understanding the Oxford-AstraZeneca Vaccine: Benefits, Risks, and Recommendations

The Oxford-AstraZeneca vaccine has shown a likely but unproven link to cerebral venous sinus thrombus and other blood clotting issues. Despite this, the benefits of vaccination still outweigh the risks, with only approximately 4 cases per million resulting in death. Communication of the potential be

0 views • 10 slides


Update on COVID-19 Vaccine Uptake in Tennessee as of October 8, 2021

In this update, Tennessee reports an increase in COVID-19 vaccine uptake with 52.8% having at least one dose and 46.7% fully immunized. The state ranks 40th in vaccine administration per 100K population. Vaccine hesitancy is addressed, and dates of FDA committee meetings on booster authorizations an

0 views • 15 slides


History of Vaccine Liability and Legal Issues in the United States

This presentation discusses the history of vaccine liability and legal battles in the United States, covering events such as the Cutter Incident, the Swine Flu vaccine campaign, and cases like Berkovitz v. U.S. It explores the challenges, consequences, and legal defenses surrounding vaccine-related

0 views • 25 slides


Michigan COVID-19 Vaccine Survey Insights

The Michigan COVID-19 Survey conducted in March 2021 provides valuable insights on vaccine segments, key findings, and likelihood to get the vaccine among residents aged 16 and older. The survey categorizes individuals into Vaccine Definites, Persuadables, and Nevers, highlighting that 61% are firml

1 views • 10 slides


Covid Confidence DWB Volunteer Session: Supporting Community with Covid Information

Empower volunteers with information on Covid issues, vaccines, testing, and myth-busting. Engage in discussions, share vaccine info, and address concerns around vaccine rollout and safety. Understand mRNA vaccines, testing speed, and safety measures in trials.

0 views • 15 slides


Update on Common Platform Implementation and Defence Preparation Activities

Early adopter rollout preparations are in progress for the Common Platform implementation in various courts across different regions. Local implementation teams have been established to engage with the Judiciary and partner agencies. Defence awareness sessions and learning guides are being provided

0 views • 5 slides


Vaccine Inventory Lot Management Job Aid

This job aid explains how Site Admins can add, edit, and manage vaccine inventory lots for clinics. Users can add new vaccine lots, edit existing entries, and associate vaccine lots with specific clinics in the system. The process involves entering lot details, NDC code, expiration, and available do

0 views • 4 slides


Global Vaccine and Immunization Research Forum 2023 Agenda

The Global Vaccine and Immunization Research Forum 2023, scheduled for March 28-30 at Grand Hyatt, Incheon, Korea, will feature keynote speakers, plenary sessions, workshops, and discussions on various topics related to vaccine research, development, and global health. The agenda includes sessions o

0 views • 9 slides


Comprehensive Community Rollout Timeline and Progress Summary

This presentation covers the community rollout agenda, introduction, key questions on who, why, when, and how, along with insights on initial rollout, progression updates, urgent release deaths, and a detailed timeline for scrutiny and review. An overview of the entire process leading to the full ro

0 views • 13 slides


COVID-19 Vaccination for People Experiencing Homelessness Presentation Overview

This presentation, developed by CDC's COVID-19 Response Vaccine Task Force and Homelessness Unit, focuses on COVID-19 vaccination basics, safety, prioritization for individuals experiencing homelessness, and strategies to overcome barriers to vaccination. It highlights the importance of understandin

0 views • 49 slides


COVID-19 Vaccine Updates and Recommendations - January 2023

New updates regarding COVID-19 vaccine administration and recommendations have been released, including the ability for clinics to create and manage vaccine supplies for children as young as six months. The Western States Scientific Review Workgroup supports the use of Moderna and Pfizer-BioNTech bi

0 views • 6 slides


NC COVID-19 Vaccine Plan Update Oct 9, 2020 Task Force Meeting Overview

The NC COVID-19 Vaccine Plan discussed in the October 9, 2020 Task Force Meeting includes details on vaccine supply, distribution goals, clinical trial timelines, safety, and outreach strategies. Key points cover vaccine development progress, trial protocols, distribution targets, and communication

0 views • 6 slides


Safety and Efficacy of BNT162b2 mRNA Covid-19 Vaccine Phase 3 Data

Phase 3 data of the BNT162b2 mRNA Covid-19 vaccine, including study design, participant groups, primary endpoints, and key findings regarding safety and efficacy. The vaccine demonstrated efficacy against confirmed Covid-19, with reported local and systemic adverse effects within a specified timefra

0 views • 48 slides


Aging and Disability Vaccine Collaborative (ADVC) Project Overview

The Aging and Disability Vaccine Collaborative (ADVC) led by Tannis Hargrove at the University of Montana aims to support vaccination education and promotion activities for older adults and people with disabilities. Through partnerships with various organizations, the ADVC provides accessible and in

0 views • 12 slides


Introduction of Gardasil HPV Vaccine in Sikkim's Routine Immunization Programme

Cervical cancer is a major health issue in Sikkim, India, prompting the introduction of the Gardasil HPV vaccine to address the high prevalence of HPV infections leading to cervical cancer. The state-wide immunization campaign targeted girls aged 9-14, aiming to incorporate the vaccine into the rout

0 views • 10 slides


COVID-19 Communication Strategy: Tackling the Fourth Wave Together

Amid the challenges in reaching vaccine targets and combating COVID-19 misinformation, a comprehensive communication strategy is outlined. Through the production of infographics, videos, and workshops in multiple languages, the focus is on promoting credible information and encouraging non-pharmaceu

0 views • 15 slides


Permutation Tests and False Detection Rate in HPV Vaccine Trial

Permutation tests are computer-intensive methods used for hypothesis testing when the distribution of the test statistic is unknown. In a hypothetical HPV vaccine trial with 200 women, the scientific question revolves around comparing infection risks in groups receiving the vaccine and placebo. The

0 views • 19 slides